Polymers as advanced antibacterial and antibiofilm agents for direct and combination therapies

The growing prevalence of antimicrobial drug resistance in pathogenic bacteria is a critical threat to global health. Conventional antibiotics still play a crucial role in treating bacterial infections, but the emergence and spread of antibiotic-resistant micro-organisms are rapidly eroding their us...

Full description

Saved in:
Bibliographic Details
Main Authors: Si, Zhangyong, Zheng, Wenbin, Prananty, Dicky, Li, Jianghua, Koh, Chong Hui, Kang, En-Tang, Pethe, Kevin, Chan-Park, Mary B.
Other Authors: School of Chemical and Biomedical Engineering
Format: Article
Language:English
Published: 2021
Subjects:
Online Access:https://hdl.handle.net/10356/154384
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Nanyang Technological University
Language: English
id sg-ntu-dr.10356-154384
record_format dspace
spelling sg-ntu-dr.10356-1543842023-02-28T16:58:47Z Polymers as advanced antibacterial and antibiofilm agents for direct and combination therapies Si, Zhangyong Zheng, Wenbin Prananty, Dicky Li, Jianghua Koh, Chong Hui Kang, En-Tang Pethe, Kevin Chan-Park, Mary B. School of Chemical and Biomedical Engineering Lee Kong Chian School of Medicine (LKCMedicine) School of Biological Sciences School of Physical and Mathematical Sciences Engineering::Chemical engineering::Polymers and polymer manufacture Polymers Antibacterial The growing prevalence of antimicrobial drug resistance in pathogenic bacteria is a critical threat to global health. Conventional antibiotics still play a crucial role in treating bacterial infections, but the emergence and spread of antibiotic-resistant micro-organisms are rapidly eroding their usefulness. Cationic polymers, which target bacterial membranes, are thought to be the last frontier in antibacterial development. This class of molecules possesses several advantages including a low propensity for emergence of resistance and rapid bactericidal effect. This review surveys the structure-activity of advanced antimicrobial cationic polymers, including poly(α-amino acids), β-peptides, polycarbonates, star polymers and main-chain cationic polymers, with low toxicity and high selectivity to potentially become useful for real applications. Their uses as potentiating adjuvants to overcome bacterial membrane-related resistance mechanisms and as antibiofilm agents are also covered. The review is intended to provide valuable information for design and development of cationic polymers as antimicrobial and antibiofilm agents for translational applications. Ministry of Education (MOE) Published version This work was funded and supported by the Singapore MOE Tier 3 grant (MOE2018-T3-1-003) 2021-12-25T05:55:53Z 2021-12-25T05:55:53Z 2022 Journal Article Si, Z., Zheng, W., Prananty, D., Li, J., Koh, C. H., Kang, E., Pethe, K. & Chan-Park, M. B. (2022). Polymers as advanced antibacterial and antibiofilm agents for direct and combination therapies. Chemical Science. https://dx.doi.org/10.1039/D1SC05835E 2041-6520 https://hdl.handle.net/10356/154384 10.1039/D1SC05835E en MOE2018-T3-1-003 Chemical Science © 2021 The Author(s). Published by the Royal Society of Chemistry. This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported LIcense. application/pdf
institution Nanyang Technological University
building NTU Library
continent Asia
country Singapore
Singapore
content_provider NTU Library
collection DR-NTU
language English
topic Engineering::Chemical engineering::Polymers and polymer manufacture
Polymers
Antibacterial
spellingShingle Engineering::Chemical engineering::Polymers and polymer manufacture
Polymers
Antibacterial
Si, Zhangyong
Zheng, Wenbin
Prananty, Dicky
Li, Jianghua
Koh, Chong Hui
Kang, En-Tang
Pethe, Kevin
Chan-Park, Mary B.
Polymers as advanced antibacterial and antibiofilm agents for direct and combination therapies
description The growing prevalence of antimicrobial drug resistance in pathogenic bacteria is a critical threat to global health. Conventional antibiotics still play a crucial role in treating bacterial infections, but the emergence and spread of antibiotic-resistant micro-organisms are rapidly eroding their usefulness. Cationic polymers, which target bacterial membranes, are thought to be the last frontier in antibacterial development. This class of molecules possesses several advantages including a low propensity for emergence of resistance and rapid bactericidal effect. This review surveys the structure-activity of advanced antimicrobial cationic polymers, including poly(α-amino acids), β-peptides, polycarbonates, star polymers and main-chain cationic polymers, with low toxicity and high selectivity to potentially become useful for real applications. Their uses as potentiating adjuvants to overcome bacterial membrane-related resistance mechanisms and as antibiofilm agents are also covered. The review is intended to provide valuable information for design and development of cationic polymers as antimicrobial and antibiofilm agents for translational applications.
author2 School of Chemical and Biomedical Engineering
author_facet School of Chemical and Biomedical Engineering
Si, Zhangyong
Zheng, Wenbin
Prananty, Dicky
Li, Jianghua
Koh, Chong Hui
Kang, En-Tang
Pethe, Kevin
Chan-Park, Mary B.
format Article
author Si, Zhangyong
Zheng, Wenbin
Prananty, Dicky
Li, Jianghua
Koh, Chong Hui
Kang, En-Tang
Pethe, Kevin
Chan-Park, Mary B.
author_sort Si, Zhangyong
title Polymers as advanced antibacterial and antibiofilm agents for direct and combination therapies
title_short Polymers as advanced antibacterial and antibiofilm agents for direct and combination therapies
title_full Polymers as advanced antibacterial and antibiofilm agents for direct and combination therapies
title_fullStr Polymers as advanced antibacterial and antibiofilm agents for direct and combination therapies
title_full_unstemmed Polymers as advanced antibacterial and antibiofilm agents for direct and combination therapies
title_sort polymers as advanced antibacterial and antibiofilm agents for direct and combination therapies
publishDate 2021
url https://hdl.handle.net/10356/154384
_version_ 1759855466032136192